Jarle Jortveit

Incidence, risk factors and outcome of young patients with myocardial infarction

Jarle Jortveit, Are Hugo Pripp, Jørund Langørgen et al. · Heart · 2020 · 139 citations

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction

Sigrun Halvorsen, Jarle Jortveit, Pål Hasvold et al. · BMC Cardiovascular Disorders · 2016 · 61 citations · Full text

BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study

John Munkhaugen, Vidar Ruddox, Sigrun Halvorsen et al. · American Heart Journal · 2018 · 50 citations · Full text

Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease

Jarle Jortveit, Sigrun Halvorsen, Anete Kaldal et al. · BMC Cardiovascular Disorders · 2019 · 42 citations · Full text